NRX Pharmaceuticals
NRXP
NRXP
18 hedge funds and large institutions have $1.21M invested in NRX Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
4% less capital invested
Capital invested by funds: $1.26M → $1.21M (-$53.8K)
Holders
18
Holding in Top 10
–
Calls
$181K
Puts
$131K
Top Buyers
| 1 | +$241K | |
| 2 | +$59.2K | |
| 3 | +$37.2K | |
| 4 |
TC
TownSquare Capital
Provo,
Utah
|
+$25.4K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$19.7K |
Top Sellers
| 1 | -$42K | |
| 2 | -$10K | |
| 3 | -$1.77K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.32K |
| 5 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$843 |